Australian Funding Commitment For New Medicines Wins Industry Thumbs Up
Executive Summary
The pharma and biotech industries have welcomed Australia’s coronavirus recovery budget, which also sets aside funding for research into COVID-19 vaccines and makes positive changes to R&D tax incentives.